Ad hoc announcement pursuant to Art. 53 LR
Baar, Switzerland, August 6, 2024
First half-year 2024 at a glance:
- Net revenue of CHF 142.1 million (H1/2023: CHF 150.2 million), reflecting a decrease of 2.7% at constant currencies (-5.4% at actual currencies). While the key markets (such as DACH region, Nordics and the Netherlands) performed in line with expectations, UK and France & Spain suffered from a shortfall. In addition, last year’s reporting period benefited from a high base effect due to a revenue catch-up after the component shortage.
- Incoming Orders 3.1% below previous year (-0.3% at constant currencies), but about 13% above H2/2023. USA & Canada, and Rest of World delivered a strong order intake with a growth rate of around 20%.
- EBITDA margin of 7.4% in line with previous year (H1/2023: 7.5%)
- Group profit of CHF 2.9 million (H1/2023: CHF 5.1 million), impacted by the increased costs of depreciation.
- Net cash position of CHF 16.5 million (H1/2023: CHF 21.2 million) with a solid equity ratio of 36.7% (H1/2023: 35.7%).
Guidance for fiscal year 2024
Given the slower start of the year and the current market and geopolitical environment, Ascom expects for fiscal year 2024:
- Net revenue in line with the previous year at constant currencies,
- EBITDA margin of 9-10%.
Key markets in line with expectations
Ascom generated in H1/2024 a net revenue of CHF 142.1 million, representing a decrease of 2.7% at constant currencies (-5.4% at actual currencies) compared to CHF 150.2 million in H1/2023, which was positively impacted by the catch-up in revenue due to the easing of the chip supply problems.
The best performance was achieved in the key markets DACH, Nordics and the Netherlands, as well as in Italy, while UK and France & Spain markets underperformed.
Revenue split by market segment showed the Healthcare sector accounting for 64% of total revenue, the Enterprise sector developed well and increased to 31%, while the OEM business contributed 5% of total revenue for the first half-year 2024.
Strong order intake in USA & Canada
In the first half-year of 2024, incoming orders were overall in line with the previous year. The total volume of new orders decreased by 0.3% at constant currencies and amounted to CHF 166.1 million, compared to CHF 171.5 million in H1/2023 (-3.1% at actual currencies).
However, incoming orders in the first six months of 2024 were about 13% higher than in the second half-year 2023 (H2/2023: CHF 147.1 million). Robust growth was achieved particularly in USA & Canada and Rest of World with an increase of about 20% compared to H1/2023 in each region.
The book-to-bill ratio remains at healthy 1.17. Order backlog further increased to CHF 311.5 million (31.12.2023: CHF 276.4 million), representing a healthy backlog for conversion in the second half-year 2024 and beyond.
EBITDA margin in line with previous year
Gross profit in the first half-year 2024 amounted to CHF 67.2 million and the gross margin reached 47.3%, the same level as in the previous year (H1/2023: 47.5%). EBITDA came to CHF 10.5 million with an EBITDA margin of 7.4% in line with the previous year (H1/2023: CHF 11.2 million with a margin of 7.5%).
EBIT was at CHF 4.0 million (H1/2023: CHF 6.1 million), mainly due to increased costs of depreciation. As a result, Ascom closed the first half-year of 2024 with a Group profit of CHF 2.9 million (H1/2023: CHF 5.1 million).
Solid balance sheet with equity ratio of 36.7%
On 30 June 2024, cash and cash equivalents amounted to CHF 21.5 million. Ascom generated free cash flow of CHF 2.1 million in the first six months (H1/2023: CHF 12.2 million). The cash flow generation was mainly impacted by the increased dividends of CHF 10.8 million paid-out in the first half-year 2024, and the investment in the refurbishing of Ascom’s facility in Gothenburg.
Ascom has outstanding borrowings of CHF 5.0 million, resulting in a net cash position (cash and cash equivalents less borrowings) of CHF 16.5 million (31.12.2023: CHF 24.7 million). As of 30 June 2024, the equity ratio stood at a solid level of 36.7% (H1/2023: 35.7%).
Strategy execution on track
Ascom is delivering upon its strategic plan to
- Become the key enabling platform for Healthcare and Enterprise;
- Step-up growth in the next couple of years;
- Strengthen Ascom’s position in solutions and software with the launch of its new standardized and integrated Healthcare and Enterprise Platforms in 2024 and 2025. The platform convergence will be completed by mid-2025;
- Enhance the gross margin and operational efficiency, enabling an EBITDA accretion over the next couple of years.
Next to its strategic transformation, Ascom is taking cost measures in 2024 to improve further its efficiency and cost base. This will result in additional run-rate savings in 2025 and beyond.
Guidance and targets for fiscal year 2024
Ascom is on track with its plan to execute its strategy and expects the second half-year 2024 to develop significantly better than the first half-year 2024 as well as the second half-year 2023.
However, taking into account the slower start of the year, as well as the current market and geopolitical environment, Ascom expects for fiscal year 2024 a revenue development in line with the previous year at constant currencies, and an EBITDA margin of 9-10%.
KEY FIGURES HALF-YEAR 2024
| In CHFm., except % | ||
| H1 2024 | H1 2023 | |
| Incoming orders | 166.1 | 171.5 |
| Order backlog (at the end of the period) | 311.5 | 289.8 |
| Net revenue | 142.1 | 150.2 |
| Gross profit | 67.2 | 71.3 |
| EBIT | 4.0 | 6.1 |
| EBIT margin in % | 2.8% | 4.1% |
| EBITDA1 | 10.5 | 11.2 |
| EBITDA margin in % | 7.4% | 7.5% |
| Group profit | 2.9 | 5.1 |
| Number of employees (FTE) at 30.06. | 1’433 | 1’368 |
1EBITDA, earnings before interest, income tax, depreciation, and amortization, see also definition in the 2024 Half-year Report on page 5.
The Half-Year Report 2024 of the Ascom Group and the Half-Year Results Presentation 2024 are available in English on https://www.ascom.com/investors/reports-and-presentations/
The Half-Year Results Conference Webcast 2024 starts on Tuesday, 6 August 2024 at 10.00 a.m. CEST.
The conference can be joined via a live audio webcast with synchronized presentation slides, including Q&A or via conference call, where participants can ask questions after the presentation.
- Live Webcast: Link Live-Audio-Webcast
- Dial-In Conference Call: Link Conference Call
- 广州四维营销:会议会务全托管,让企业招商会 “落地即成交”
- 平安人寿联合复旦大学重磅发布《新纪元·新价值:迎接黄金发展期》寿险行业白皮书
- 2025亚洲国际音乐大赛新加坡总决赛颁奖典礼精彩纷呈
- 十一度蝉联保险业第一!BrandZ《最具价值中国品牌100强》发布:中国平安位列中国品牌第九
- 3岁女童总爱凑近皱眉看人,检查竟非近视,而是得了“老年病”——福州爱尔眼科
- 2025上海别墅装修公司有哪些?高性价比推荐:1299 元 /㎡享品质装修
- 千金药业:1.5亿智能车间圆满封顶 女性健康产业升级加速
- 林华寿独创道家古法疗法攻克三尸虫取得重大突破
- 新愿景,新启航!研华加速从IPC迈入边缘计算新时代
- PIK3CA基因检测助力乳腺癌精准治疗新篇章
- 伽澜健康助力黄河金三角区域医疗机构临床营养学科建设论坛圆满举办
- 立屯精神聚合力 政企共建助振兴—中国人寿财险广西分公司联合天等县开展主题党日活动
- 《StellarSugar》12强选手惊现韩国最大中餐厅:燕京大饭店
- 有梦有方向 青春正飞扬 “青春影像”校园歌手征集最终展示活动将在重庆举办
- 山东双嘉家庭教育走进历城一中:开展心理讲座赋能青春梦想